Covance Is Now Labcorp Drug Development

We are one global company innovating for millions – together, continuing to bring you more advanced medical breakthroughs.

Learn More


Patient-Centric Hub Design: Driving Adherence and Affordability

More than 350 million people live with over 7,000 identified rare diseases worldwide. Being patient-centric calls for innovation in service (not just technology), particularly for specialized needs associated with rare diseases. Today, along with an increased ability to treat these diseases, we see extra pain points in the patient journey. How can high-touch coordination help bridge the gaps between diagnosis and treatment?

Filed In

Market Access Strategy
Patient Centricity